Squarepoint

Squarepoint’s Crescent Biopharma CBIO Stock Holding History

Squarepoint’s Portfolio CBIO Stock Details CBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-203	Closed	-$60.9K	–	4311
2024 Q1	$60.9K	Buy	+203	New	+$60.6K	﹤0.01%	3861
2021 Q3	–	Sell	-162	Closed	-$38K	–	3105
2021 Q2	$38K	Buy	+162	New	+$41.2K	﹤0.01%	3124
2021 Q1	–	Sell	-399	Closed	-$150K	–	3299
2020 Q4	$150K	Buy	399 +81	+25%	+$28.4K	﹤0.01%	2620
2020 Q3	$98K	Sell	318 -178	-36%	-$68K	﹤0.01%	2291
2020 Q2	$187K	Sell	496 -378	-43%	-$107K	﹤0.01%	1838
2020 Q1	$199K	Buy	874 +136	+18%	+$52K	0.01%	1479
2019 Q4	$390K	Buy	738 +250	+51%	+$135K	﹤0.01%	1903
2019 Q3	$210K	Buy	+488	New	+$314K	﹤0.01%	2056
2019 Q1	–	Sell	-841	Closed	-$797K	–	2255
2018 Q4	$797K	Buy	841 +607	+259%	+$730K	0.01%	1013
2018 Q3	$337K	Buy	+234	New	+$354K	﹤0.01%	1479
2017 Q4	–	Sell	-375	Closed	-$524K	–	2179
2017 Q3	$524K	Buy	+375	New	+$440K	0.01%	961

Other funds holding CBIO

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Acadian Asset Management

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Millennium Management

Millennium Management New York $134B AUM 35.51% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return